Novotech Earns Renewed Certification As An Employer Of Choice For Gender Equality

Novotech, a global biotech specialist CRO, proudly announces its continued recognition as a Workplace Gender Equality Agency (WGEA) Employer of Choice for Gender Equality (EOCGE) in 2024. This marks another milestone in Novotech's ongoing commitment to fostering an inclusive and equitable workplace.

The EOCGE citation, a prestigious accolade in Australia's business landscape, acknowledges organisations that demonstrate exceptional dedication to achieving gender equality. This voluntary program recognises employers who go above and beyond in creating an environment where all employees, regardless of gender, can thrive and succeed.

Dr. John Moller, CEO of Novotech Holdings, stated: "Receiving this re-certification in 2024 is a testament to our unwavering dedication to diversity and inclusion. It reflects the collective effort of our entire organisation to champion these values. As we expand globally, we're committed to extending these best practices across all our operations, aiming to inspire positive change throughout our industry."

Angela Edwardson, Chief People Officer of Novotech Holdings, added: "Our journey towards gender equality is an ongoing process deeply embedded in our corporate culture. The initiatives we've implemented as a WGEA Employer of Choice are not just policies on paper; they shape our daily operations, influence our strategic decisions, and contribute to a workplace environment that nurtures talent irrespective of gender."

Novotech stands out among the select group of Australian employers in maintaining this prestigious citation, showcasing its sustained commitment to gender equality. As the company continues to grow and evolve, its dedication to creating an inclusive, diverse, and equitable workplace remains at the forefront of its organisational values, positively impacting the lives and careers of our employees.

The WGEA Employer of Choice for Gender Equality citation reaffirms Novotech's position as a leader in workplace equality. It not only sets a benchmark for the biotech and CRO sectors in Australia and internationally but also inspires others to follow suit, making us all proud to be a leader of this positive change in our industry.